The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISTH 2023 | Exigency study: exploring the impact of steroids following gene therapy for hemophilia
Simon Fletcher, MA, BA (Hons), Dip N, RGN , Haemnet / Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the results of the Exigency study (NCT04723680), which investigated the impact of gene therapy on the lives and families of patients with hemophilia. In this interview, Mr Fletcher focuses on the challenges experienced by patients taking steroids, which are often required alongside gene therapy. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
